跳至主要内容
临床试验/NCT01404364
NCT01404364已完成不适用

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

Hospital Governador Celso Ramos1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
Changes in Pain intensity

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of ocular pain in blind eyes.

详细描述

The management of chronic eye pain is a constant challenge to ophthalmology. Treatment varies with the intensity of pain, and topical eye drops and contact lens therapy are effective in many patients. In refractory cases, and without vision, surgical removal of the eye through enucleation is considered classical therapy. As less invasive alternatives we have cyclodestruction and neurolytic drug injection in order to promote analgesia for a prolonged period.

The purpose of this study is to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of This is a prospective study of patients with blind painful eyes not responsive to topical treatment and with no indication for evisceration seen at the Department of Ophthalmology, Hospital Governador Celso Ramos (HGCR) in 2010.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients treated in the period at HGCR who wanted to be part of the protocol by signing the consent form

排除标准

  • patients whose follow-up period was less than three months

研究组 & 干预措施

Intravitreal Triamcinolone

Active Comparator

Patients with phthisis bulbi received 0,3ml intravitreal triamcinolone injection

干预措施: Triamcinolone (Drug)

Retrobulbar Chlorpromazine

Active Comparator

Patients with refractory glaucoma and blind painful eye were submitted to 2,5mL Chlorpromazine retrobulbar injection

干预措施: Chlorpromazine (Drug)

结局指标

主要结局

Changes in Pain intensity

时间窗: 0, 1 month, 3 months, 6 months after procedure

Pain was measured asking the patient to graduate it in a scale from 0 to 10, 0 being no pain, 10 being the worst pain patient has experienced in life

次要结局

  • Changes in Use of eyedrops before and after drug injection(0, 1 month, 3 months, 6 months)
  • Changes in Intraocular pressure (IOP)(0, 1 months, 3 months, 6 months)

研究者

发起方
Hospital Governador Celso Ramos
申办方类型
Other

研究点 (1)

Loading locations...

相似试验